We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App




Software Reduces MRI Breath Holding Up to 50%

By MedImaging International staff writers
Posted on 13 May 2013
New software decreases patient magnetic resonance imaging (MRI) breath-hold time up to 50% without surrendering image resolution, enabling ultra-fast, high-quality three-dimensional (3D) T1 imaging.

Siemens Healthcare (Erlangen, Germany) recently reported the US Food and Drug Administration (FDA) recently cleared the company’s CAIPIRINHA (controlled aliasing in volumetric parallel imaging results in higher acceleration) software as part of Siemens’ syngo MR D13A software package for parallel magnetic resonance (MR) imaging. The software helps enable patients with breath-holding difficulties to cut the amount of time they hold their breath without sacrificing imaging resolution or contrast.

Siemens’ CAIPIRINHA software enables acquisition of better quality 3D volumetric interpolated breath-hold sequence (VIBE) T1 images using higher acceleration factors. CAIPIRINHA software will be included as standard with Siemens’ D13A software for Magnetom Aera 1.5 Tesla and Magnetom Skyra 3T MRI systems; it will be available with Siemens’ B19 software as an upgrade for Siemens’ Magnetom Avanto 1.5T and MagnetomVerio 3T systems.

Related Links:

Siemens Healthcare


Mammo DR Retrofit Solution
DR Retrofit Mammography
MRI System
nanoScan MRI 3T/7T
Pocket Fetal Doppler
CONTEC10C/CL
Multi-Use Ultrasound Table
Clinton

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.